MBRX Moleculin Biotech Inc

Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:45 AM ET on Thursday, June 25th with the first live webcast at 10:00 AM ET.

REGISTER NOW AT: https://tinyurl.com/062520LSIFAgendaPR

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

Agenda and presenting companies:

EasternTime (ET)	Company	Ticker
10:00 AM	RedHill Biopharma Ltd.	Nasdaq: RDHL
10:30 AM	Orexo AB	OTCQX: ORXOY | Nasdaq STO: ORX
11:00 AM	Citius Pharmaceuticals, Inc.	Nasdaq: CTXR
11:30 AM	SWK Holdings, Inc	Nasdaq: SWKH
12:00 PM	Starpharma Holdings Ltd.	OTCQX: SPHRY | ASX: SPL
12:30 PM	CNS Pharmaceuticals, Inc.	Nasdaq: CNSP
1:00 PM	Sixth Wave Innovations Inc.	OTCQB: ATURF | CSE: SIXW | FSE: AHUH
1:30 PM	Moleculin Biotech, Inc.	Nasdaq: MBRX
2:00 PM	Novan, Inc.	Nasdaq: NOVN

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACTLife Sciences Investor ForumJohn M. ViglottiSVP Corporate Services, Investor Access(212) 220-2221johnv@lifesciencesinvestorforum.com